Adaptimmune Overview

Life ScienceCompany

Where is Adaptimmune headquartered?

Adaptimmune is headquartered in Abingdon, United Kingdom.

What is Adaptimmune’s revenue?

Adaptimmune disclosed revenue of 178M USD for 2024 and 60M USD for 2023.

How many employees does Adaptimmune have?

Adaptimmune has 506 employees.

What sector is Adaptimmune in?

Adaptimmune is a life science company.

When was Adaptimmune founded?

Adaptimmune was founded in 2008.

Adaptimmune

Adaptimmune Therapeutics plc

60 Jubilee Avenue, Milton Park,
Abingdon, OX14 4RX
United Kingdom,
+44 12 3543 0000
www.adaptimmune.com

Adaptimmune is a clinical-stage biopharmaceutical company that focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide-enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposarcoma indications (MRCLS); in phase II clinical trials with SPEARHEAD-2 for patients with head and neck cancer; and in phase I clinical trials for urothelial, melanoma, head and neck, ovarian, non-small cell lung, esophageal and gastric, synovial sarcoma, and MRCLS cancers. Adaptimmune was founded in 2008 and is based in Abingdon, England.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.0/yr) # - - - - - - 0
Sell (0.2/yr) # - - - - - 1 1
vol $55M $55M
  1

Top M&A Advisors

Financial Deals
Cowen
1
Legal Deals
Ropes & Gray
1

Try Mergr Free — See This and 220,830+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Adaptimmune

Life Science Companies , United Kingdom Companies